19-25 January 2010

 

Previous edition
January, 12-18
 
Upcoming Events
26-27 January - ADME, PK/TK and Drug Metabolism in Drug Discovery and Development, Brussels, Belgium
26 - 27  January  EFGCP Annual Conference 2010 - Aspects of Personalised Medicine for Society - A Challenge Yet to be Met,  Brussels, Belgium
1 - 2 February Biosquare 2010, Geneva, Switzerland
 

Suscribe to our RSS feed
 

Follow us


Twitter
 


Facebook
 

Watch our videos on Youtube

Join us on Facebook

 

EuropaBio Weekly
subscribe EuropaBio Weekly
unsubscribe EuropaBio Weekly


EuropaBio
Avenue de l'Armée 6
B-1040 Brussels, Belgium
Tel: +32 2 735 03 13
Fax: +32 2 735 49 60

http://www.europabio.org

              
If you can not read this newsletter, click here

 

Headlines

  Event - EFGCP Annual Conference 2010 - Aspects of Personalised Medicine for Society - A Challenge Yet to be Met, Brussels, Belgium - 26 & 27 January 2010.
 
 
 

Green Biotech (top)

  Organic farmers must embrace GM crops if we are to feed the world, says scientist
The organic movement should overcome its hostility to genetically modified crops and embrace the contribution that they can make to sustainable farming, one of the world’s leading agricultural scientists has told The Times.
 
 
  British researchers develop GM potato
A trial to develop genetically modified potatoes that would save British growers more than £40 million a year has been successful, initial results have revealed.
 
 
  Africa food woes blamed on Europe’s hypocrisy
Europe’s resistance to genetically modified crop production in Africa is a major challenge to tackling Africa’s food insecurity, according to experts.

 
 
 

Red Biotech (top)

  Study uncovers costs of drug resistance for bacteria 
Developing resistance to certain antibiotics may come at a price for the bacteria, new Swedish research suggests. Sara Thulin Hedberg of Örebro University studies the bacteria Neisseria meningitidis, one of the main causes of meningitis. She found that bacteria that are resistant to the drug rifampicin do not reproduce as fast as non-resistant bacteria and are not as good at infecting people. She hopes that her findings, which form part of her doctoral dissertation, will lead to the development of new, more effective antibiotics. 

 
 
  More mergers and acquisitions ahead for 2010
Many life sciences companies are likely to execute an acquisition in the next 12–24 months as economic conditions improve, according to Why capital matters, a global survey of senior executives in the life sciences sector conducted by Ernst & Young in 2009. Respondents believed 2010 would offer many transaction opportunities and a strong majority of respondents rated the outlook for merger and acquisitions as "favorable" or "very favorable" during the next 12 months.
 
 
 

White Biotech (top)

 

Biofuel R&D updates
The biofuel industry might be struggling right now but advanced technology developments are definitely still alive and kicking -- especially if government grants and funding from both public and private sector are flowing in.
 

 
 

Other (top)

  EU plans SME help centres across the world
The EU executive is planning to open a string of new offices across the world to help small businesses expand into new markets, but Brussels is wary of stepping on the toes of national agencies and private organisations which already provide such services, according to European Commission documents seen by EurActiv.